Condition: Gout Arthritis · Gout Attack · Sponsor: Laboratorios Silanes S.A. de C.V.
Phase III longitudinal, multicenter, randomized, double-blind clinical trial. The aim of this study is to evaluate the efficacy and safety of the Fixed-Dose Combination of Etoricoxib/Betamethasone Versus Etoricoxib in Patients With Acute Gouty Arthritis
This description comes directly from the study's public registry record.
Jorge A Gonzalez, PhD · 5254883785 · jogonzalez@silanes.com.mx
Yulia Romero-Antonio, B.S. · 5254883785 · yromero@silanes.com.mx
Always discuss trial participation with your own doctor first.
| Laboratorio Silanes, S.A. de C.V. | Mexico City, Mexico | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06863701